Searchable abstracts of presentations at key conferences in endocrinology

ea0042p36 | (1) | Androgens2016

Androgen and Estrogen Receptor Co-regulation of Human UDP-glucuronosyltransferases 2B15 and 2B17 in Breast Cancer

Hu Dong Gui , Selth Luke , Tarulli Gerard , Meech Robyn , Wijayakumara Dhilushi , Chanawong Apichaya , Russell Roslin , Caldas Carlos , Robinson Jessica LL , Carroll Jason , Tilley Wayne , Mackenzie Peter , Hickey Theresa

Glucuronidation is an enzymatic process that terminally inactivates steroid hormones, including estrogens and androgens, thereby influencing carcinogenesis in hormone-dependent cancers. While estrogens drive breast carcinogenesis via the estrogen receptor alpha (ERα), androgens play a critical role as prohormones for estrogen biosynthesis and ligands for the androgen receptor (AR). Herein, the expression and regulation of two androgen inactivating UDP-glucuronosyltransfer...

ea0054is4 | (1) | NuclearReceptors2018

Estrogen receptor cistromics in breast tumors: from biomarkers to novel drug targets

Flach Koen Dorus , Periyasamy Manikandan , Jadhav Ajit , Hickey Theresa E , Opdam Mark , Patel Hetal , Canisius Sander , Wilson David M , Dorjsuren Dorjbal , Nieuwland Marja , Kluin Roel , Zakharov Alexey V , Wesseling Jelle , Wessels Lodewyk Frederik Ary , Linn Sabine Charlotte , Tilley Wayne D , Simeonov Anton , Ali Simak , Zwart Wilbert

Estrogen receptor α (ERα) is a key transcriptional regulator in the majority of breast cancers. ERα-positive patients are frequently treated with tamoxifen, but resistance is common. Through ChIP-seq analyses, we presviously identified direct target genes of ERα acting in complex with SRC1, SRC2 or SRC3 (Zwart et al., 2011 EMBO J). Only the 111 genes there were under direct control of ERα in conjunction with SRC3 (but not the other two p160s) predicted...